Medifast Inc $MED Position Boosted by State of Wyoming

Key Points

• The State of Wyoming increased its holdings in Medifast Inc. by 184.1%, acquiring an additional 20,825 shares to total 32,137 shares, valued at approximately $433,000.
• Medifast reported earnings of $0.04 per share, surpassing analysts' expectations of ($0.22), and revenue of $105.56 million for the quarter.
• Institutional investors collectively own 95.51% of Medifast's stock, indicating strong institutional confidence in the company.

State of Wyoming lifted its position in shares of Medifast Inc (NYSE:MED - Free Report) by 184.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,137 shares of the specialty retailer's stock after buying an additional 20,825 shares during the quarter. State of Wyoming owned approximately 0.29% of Medifast worth $433,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Northern Trust Corp increased its position in Medifast by 0.9% in the 4th quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer's stock valued at $1,793,000 after acquiring an additional 871 shares during the period. SummerHaven Investment Management LLC increased its stake in shares of Medifast by 2.2% in the 1st quarter. SummerHaven Investment Management LLC now owns 42,073 shares of the specialty retailer's stock valued at $567,000 after buying an additional 916 shares during the period. Wells Fargo & Company MN lifted its holdings in Medifast by 23.5% during the fourth quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer's stock worth $114,000 after acquiring an additional 1,227 shares in the last quarter. Barclays PLC raised its holdings in Medifast by 15.1% during the fourth quarter. Barclays PLC now owns 16,194 shares of the specialty retailer's stock worth $285,000 after acquiring an additional 2,127 shares in the last quarter. Finally, Values First Advisors Inc. increased its stake in shares of Medifast by 3.8% during the first quarter. Values First Advisors Inc. now owns 64,228 shares of the specialty retailer's stock worth $869,000 after purchasing an additional 2,340 shares during the period. Hedge funds and other institutional investors own 95.51% of the company's stock.

Medifast Stock Down 1.8%

MED traded down $0.25 during midday trading on Friday, hitting $13.60. 76,315 shares of the company were exchanged, compared to its average volume of 222,982. The firm's 50 day moving average price is $13.98 and its 200-day moving average price is $13.65. The firm has a market capitalization of $149.51 million, a P/E ratio of 42.46 and a beta of 0.82. Medifast Inc has a 1-year low of $11.57 and a 1-year high of $21.98.

Medifast (NYSE:MED - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.26. The company had revenue of $105.56 million during the quarter, compared to analyst estimates of $96.10 million. Medifast had a return on equity of 2.00% and a net margin of 0.76%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. On average, sell-side analysts predict that Medifast Inc will post 0.51 earnings per share for the current fiscal year.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.